Sign in Register

Seebri Neohaler (glycopyrrolate)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

USES: Glycopyrrolate is a long term medication used to treat ongoing lung disease such as chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It must be used regularly to reduce and prevent symptoms such as shortness of breath and wheezing. This may lead to a decrease in time lost from work due to COPD.

This medication belongs to a class of drugs known as anticholinergics. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Glycopyrrolate does not work right away and should not be used to relieve sudden breathing problems.

If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed.

Generic name: glycopyrrolate
Pronunciation: (GLYE-koe-PIR-oh-late)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Seebri Neohaler

Intelligence content is not available yet.

Indications

The following indications are listed for Seebri Neohaler:

  • Bronchospasm Prevention With Copd

Also known as: Copd With Bronchospasms Prophylaxis.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a 5-digit ZIP code. Searching does not change your profile.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data